Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Ram

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|September 16, 2022
An optimized Factor H-Fc fusion protein against multidrug-resistant <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Aleyo Chabeda, Y Tran, et al.
Cell Host & Microbe|June 10, 2025
Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolismEvelyn A Kurt-Jones, Sunita Gulati, Michael King, et al.
Frontiers in Microbiology|January 31, 2019
<i>Candida albicans</i> Factor H Binding Molecule Hgt1p - A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human NeutrophilsSamyr Kenno, Cornelia Speth, Günter Rambach, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeaeJutamas Shaughnessy, Sunita Gulati, Sarika Agarwal, et al.
Mbio|January 20, 2021
Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzaeSudeshna Saha, Alison Coady, Aniruddha Sasmal, et al.
Mbio|March 17, 2021
Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal InfectionElizabeth M Parzych, Sunita Gulati, Bo Zheng, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
The Journal of Biological Chemistry|October 4, 2003
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificitySanjay Ram, Andrew D Cox, J Claire Wright, et al.
Mbio|November 19, 2015
DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria PatientsIsabella C Hirako, Carolina Gallego-Marin, Marco A Ataide, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|September 16, 2022
An optimized Factor H-Fc fusion protein against multidrug-resistant <i>Neisseria gonorrhoeae</i>Jutamas Shaughnessy, Aleyo Chabeda, Y Tran, et al.
Cell Host & Microbe|June 10, 2025
Interferon-epsilon, an estrogen-induced type I interferon, is uniquely exploited by Neisseria gonorrhoeae via effects on sialic acid metabolismEvelyn A Kurt-Jones, Sunita Gulati, Michael King, et al.
Frontiers in Microbiology|January 31, 2019
<i>Candida albicans</i> Factor H Binding Molecule Hgt1p - A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human NeutrophilsSamyr Kenno, Cornelia Speth, Günter Rambach, et al.
NPJ Vaccines|June 8, 2026
Pre-clinical efficacy of a candidate outer membrane vesicle gonococcal vaccine in comparison with 4CMenBPaula Freixeiro, Lisa A Lewis, Leonor Sánchez-Busó, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeaeJutamas Shaughnessy, Sunita Gulati, Sarika Agarwal, et al.
Mbio|January 20, 2021
Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzaeSudeshna Saha, Alison Coady, Aniruddha Sasmal, et al.
Mbio|March 17, 2021
Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal InfectionElizabeth M Parzych, Sunita Gulati, Bo Zheng, et al.
The Journal of Infectious Diseases|December 31, 2021
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal ComplementLisa A Lewis, Sunita Gulati, Wioleta M Zelek, et al.
The Journal of Biological Chemistry|October 4, 2003
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificitySanjay Ram, Andrew D Cox, J Claire Wright, et al.
Mbio|November 19, 2015
DNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria PatientsIsabella C Hirako, Carolina Gallego-Marin, Marco A Ataide, et al.
Pageof 15